Breaking the mucin barrier in #pseudomyxomaperitonei we have defeated the mucin to find the protein profile in PMP!! Allow us to get some new targets for treatment …calproceduresonline.biomedcentral.com/articles/10.11… ,@imibic Hospital Universitario Reina Sofía SEOQ | Los cirujanos del cáncer #operarelcancer Asociación Española Contra el Cáncer INDEPSO Pseudomyxoma Survivor Appendix Cancer PMP Research Foundation

2/10 Tras la resección quirúrgica, el enfoque tradicional ha sido el seguimiento, sin tratamiento adyuvante efectivo, pero el estudio BILCAP, publicado en Lancet Oncology en 2019, cambió esta perspectiva. #BILCAP 💡pubmed.ncbi.nlm.nih.gov/30922733/

📢Nueva Junta Directiva SET 2024-2026 #SET2024 con el Dr. Constantino Fondevila Constantino Fondevila como Presidente SET ¡Enhorabuena a la nueva Junta! setrasplante.org

Hyperthermic intraperitoneal chemotherapy in colorectal cancer
➡️doi.org/10.1093/bjsope…

This is a large multicentric global study combining a number of large national peritoneal surface oncology databases from three continents (39 centres) for evaluating the use and choice of

🚨 Only 5⃣ DAYS left until #ESSO43 #AbstractSubmission 🚨 Don't miss out on the opportunity to get max exposure for your #research & findings!
👉esso43.org/abstracts/
#surgicaloncology Julio Mayol Steven D Wexner MD, PhD European Journal of Surgical Oncology touchONCOLOGY OncoAlert @Some4SurgeryITeam Cancerworld

6⃣ DAYS left until #AbstractSubmission deadline!
Submit your abstracts for #ESSO43 at 👉esso43.org/abstracts/
🎯🗓️ by 15 May, 2024

Carmela Caballero Eduard-Alexandru Bonci Pallvi Kaul Nada Santrac Dana Sochorova NikolaosVassos

Released Istituto Tumori our last paper showing invitro #HIPEC on peritoneal metastasis CRC #organoids as model for #precision #therapy . Again, the oxaliplatin regimen @ high concentration for 30 mins is the least effective jeccr.biomedcentral.com/articles/10.11…
Paul H Sugarbaker BJS Peritoneal Surface Oncology Group International

#TORPEDO - early outcomes in Journal of Gynecologic Oncology

PFS (primary end-pt) data are now mature- will be presented later this year 🤞
✅Primary end-pt achieved !!

What's next? Multi-centre, multi-region validation
🔪 variations +path data

🚫NOT FOR ROUTINE CARE YET
ejgo.org/DOIx.php?id=10…

🎯 Save the date! For this 🆓 ESSO Webinar on the #Surgical Management of Small Intestinal #NeuroendocrineTumors
All info 👉 essoweb.org/courses/esso-w…
EYSAC Stefan Stättner Stefano Partelli Julie Hallet Simona Glasberg

Great work from my superb colleague Rich Owen presenting our European collaborative POPEC study. Looking cytology in gastric cancer surgery. Nuffield Department of Surgical Sciences

📣 Calling #HPB surgeons - residents, fellows, and consultants! Join us for the ESSO Advanced course on #PancreaticCancerSurgery . Gain insights into #surgicaltechniques , complications management & more.
📅 September 12-13, 2024 in Milan, IT. Enroll now!
👉 buff.ly/4aiAlu3

🌟14th congress Peritoneal Surface Oncology Group International ISSPP
🗓️Sept 26-28 2024
📍Lyon, France
📌REGISTRATION OPEN !

➡️tinyurl.com/ylqqvf99

Comienza la sesión 'Best Paper Sesión' #ECTES24 European Society for Trauma & Emergency Surgery. Llegar hasta aquí ya es un premio.👏👏👏👏
Cirugía General y Digestiva H.U. La Paz, Madrid Cirugía General y Digestiva H.U. La Paz, MadridRes AECUrg Pablo Ottolino Carlos Yanez MD, MSc, FACS

Delphi Study on PIPAC Published in the EJSO :IMPACT study group , congratulation all and happy and proud to contribute to this with colleagues , Prof. Wouter Willaert Prof. Wim Ceelen Dr. Niki Rashidian Dr. Eduard Callebaut Dr. Martin Hübner Dr. Olivia Sgarbura Dr. Francesca

“La cirugía es curativa y de hecho, en cáncer es la herramienta ahora mismo que, sin duda, más pacientes cura” (Dra. Delia Cortés Guiral ) 🩻🩺🖋️ seoq.org/entrevista-del…

It’s always a pleasure to hear Brendan Moran talk and today was no different. The pearls of wisdom and the nuggets of personal sharing were invaluable!

Very important achievement for #cytoreductive surgery and IP chemotherapy in pmGC today in #NCCN guidelines

There is definitely a place for IP chemotherapy for our patients

More data needed to fulfill the expectations and trust given to us

European Society of Surgical Oncology (ESSO) ISSPP Peritoneal Surface Oncology Group International

nccn.org/guidelines/gui…
PIPAC for Gastric cancer in the 2024 National Comprehensive Cancer Network (NCCN) guidelines
ISSPP Peritoneal Surface Oncology Group International SEOQ | Los cirujanos del cáncer #operarelcancer SEOM Asociación Peritoneum Viamed Salud SoMe4Peritoneum Dr.Mohammad ALYAMI Olivia Sgarbura Martin Hübner Wim Ceelen European Society of Surgical Oncology (ESSO)

Surgical benchmarking ?

Peritoneal Surface Oncology Group International The best systemic therapy adjuvating the best CRS is the answer. Systemic therapy cannot make up for suboptimal CRS, no matter how good results the former might show. The global result should always be better by maintaining high standard CRS.